It has also been shown that an increase in CX3CL1 expression in the tumour is linked to improved prognosis of many cancer patients with breast carcinoma (69), colorectal cancer (70, 71) or lung adenocarcinoma (72), among other cancers (70–75). This evidence concerns the gene CX3CL1 and colorectal cancer.